Ophthotech Corp. (OPHT)

[doingmybest]

I would not recommend judging upcoming P3 by market signals. Blinded P3 trials are kept pretty tight and you cannot read the market well nor can you trust it even if you could. I would rely on your due diligence. And, I would say the company has done a minimal number of studies to date but all of them have shown consistent impressive results. There is reason to be bullish but not because of the market movement but always be weary of binary situations. I think P3 will succeed, but that is only my opinion.